Use access key #2 to skip to page content.
$47.45 -2.16 (-4.35%)
10/6/2008 4:06 PM

Medtronic, Inc. (MDT)

CAPS Rating:
****

A medical technology Company alleviating pain, restoring health, and extending life for millions of people around the world.

View All Commentary (MDT)

Recs

7

Avatar stanton17 (87.93) Submitted: 1/11/07 3:36 PM : Outperform Start Price: $52.81 MDT Score: 16.51

Revenue growth has averaged 14% over the past five years. We expect 10% top-line growth, as sales of defibrillators slowly recover over the next two years, and spinal, neurological, and diabetes products continue to rack up double-digit sales growth.

Profitability Medtronic enjoys: net margins in the low to mid-20s, with returns on invested capital that are more than double the firm's cost of capital.

With financial leverage at a low 1.8 and plenty of free cash flow to repay its obligations, Medtronic remains in healthy financial condition.

Report this Post Replies: 1 | Reply

Avatar Denysnmd (88.54) Submitted: 5/25/07 6:09 PM

Recs: 0 | Rec This

Why do you expect sales of defibrillators to recover over the next two years? Why do you expect double-digit sales growth to continue? Do they have superior patent protected products? Are they innovating new products that will drive double-digit sales growth? There are a lot a bad reasons sales growth might occur too. I just can't Rec something that only gives statements of belief without underlying facts to support the reasoning.

Report this Post Reply

Featured Broker Partners